Purpose Single-photon emission computed tomography (SPECT) combined with computed
tomography (CT) was introduced as a hybrid SPECT/CT imaging modality two decades ago …

The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …

Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …

Purpose The standard of care for differentiated thyroid carcinoma (DTC) includes surgery,
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …

The term theranostics is the combination of a diagnostic tool that helps to define the right
therapeutic tool for specific disease. It signifies the “we know which sites require treatment …

Simple Summary According to the American Cancer Society, approximately 53,000 new
cases of thyroid cancer were diagnosed and more than 2200 people died from the disease …

The combined use of diagnostic and therapeutic radioligands with the same molecular
target, also known as theranostics, enables accurate patient selection, targeted therapy, and …

Introduction Efficient therapy of recurrent differentiated thyroid cancer (DTC) is dependent on
precise molecular imaging techniques targeting the human sodium iodide symporter (hNIS) …

Simple Summary This study was prompted to assess the diagnostic performance of 123I-Dx-
WBS-SPECT/CT in the identification of incomplete structural response in the early follow-up …

Background Repeated radioiodine (131 I) treatment (RT) are commonly performed in
patients with 131 I-avid distant metastatic differentiated thyroid cancer (DM-DTC), but more …